Glucagon-like peptide-1(7-36) amide enhances insulin-stimulated glucose uptake and decreases intracellular cAMP content in isolated rat adipocytes

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1312, Issue 2, 1996, Pages 132-136

  Miki, Hiroyuki ^a   Namba, Mitsuyoshi ^a   Nishimura, Takamichi ^a   Mineo, Ikuo ^b   Matsumura, Toshiko ^a   Miyagawa, Jun Ichiro ^a   Nakajima, Hiromu ^a   Kuwajima, Masamichi ^c   Hanafusa, Toshiaki ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b Otemae Hospital   (Japan)

^c UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Adipocyte; cAMP; Glucagon like peptide 1(7 36)amide; Glucose uptake; Rat

Indexed keywords

CYCLIC AMP; GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; INSULIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GLUCOSE TRANSPORT; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030582130     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-4889(96)00032-8     Document Type: Article

References (24)

1. [1] Ebert, R. and Creutzfeld, W. (1987) Diabetes Metab. Rev. 3, 1-16.
2. [2] Dupre, J. (1991) The Endocrine Pancreas (Samols, E, ed.), pp. 253-281, Raven Press, New York, .
3. [3] Unger, R.H. and Eisentraut, A.M. (1969) Arch. Intem. Med. 123, 261-266.
4. [4] Siegel, E.G., Schulze, A., Schmidt, W.E. and Creutzfeldt, W. (1992) Eur. J. Clin. Invest. 22, 154-157.
5. [5] Kreymann, B., Ghatei, M.A., Williams, G. and Bloom, S.R. (1987) Lancet 2, 1300-1303.
6. [6] Holst, J.J., Ørskov, C., Vagn, Nielsen, O. and Schwartz, T.W. (1987) FEBS Lett. 211, 169-174.
7. [7] Pipeleers, D.G., Schuit, F.C., In't Veld, P.A, Maes, E., Hooghe-Peters, E.L., Van De Winkel, M. and Gepts, W. (1985) Endocrinology 117, 824-833.
8. [8] Schuit, F.C. and Pipeleers, D.G. (1985) Endocrinology 117, 834-840.
9. [9] Gutniak, M., Ørskov, C., Holst, JJ., Ahren, B. and Efendic, S. (1992) N. Engl. J. Med. 326, 1316-1322.
10. [10] Valverde, I., Mérida, E., Delgado, E., Trapote, M.A. and Villanueva-Peñacarrillo, M.L. (1993) Endocrinology 132, 75-79.
11. [11] Mérida, E., Delgado, E., Molina, Villanueva-Peñacarrillo, M.L. and Valverde, I. (1993) J. Clin. Endoclinol. Metab. 77, 1654-1657.
12. [12] Lawrence, J.C., Jr., Piper, R.C., Robinson, L.J. and James, D.E. (1992) Proc. Natl. Acad. Sci. USA 89, 3493-3497.
13. [13] Lönnroth, P., Davies, J.I., Lönnroth, I. and Smith, U. (1987) Biochem. J. 243, 789-795.
14. [14] Gliemann, J. Methods Diabet. Res. (1985) 106-118.
15. [15] Nathan, D.M., Schreiber, E., Fogel, H., Mojsov, S. and Habener, J.F. (1992) Diabet. Care 15, 270-276.
16. [16] Nauck, M.A., Heimesaat, M.M., Ørskov, C., Holst, J.J., Ebert, R. and Creutzfeldt, W. (1993) J. Clin. Invest. 91, 301-307.
17. [17] Fürnisinn, C., Ebner, K. and Wsldhäusl, W. (1995) Diabetologiia 38, 864-867.
18. [18] Seino, S., Welsh, M., Bell, G.I., Chan, S.J. and Stener, D.F. (1986) FEBS Lett. 203, 25-30.
19. [19] Komatsu, R., Matsuyama, T., Namba, M., Watanabe, N., Itoh, H., Kono, N. and Tarui, S. (1989) Diabetes 38, 902-905.
20. [20] Schmidt, W.E., Siegel, E.G. and Creutzfeldt, W. (1985) Diabetlogia 28 704-707.
21. [21] Ørskov, C., Rabenenh ØJ, L., Wettergren, A., Kofod, H and Holst, JJ., (1994) Diabetes 43 535-539.
22. [22] James, D.E., Hiken, J.F. and Lawrence, J.C. Jr. (1989) Proc. Natl. Acad. Sci. USA 86, 8368-8372.
23. [23] Reusch, J.E.-B., Sussman, K.E. and Drazin, B. (1993) J. Biol. Chem 268, 3348-3351.
24. [24] Begum, N., Leinter, W., Reusch, J.E.-B., Sussman, K.E. and Drazin, B. (1993) J. Biol. Chem 268, 3352-3356.